Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Syndecan 4 ELISA Kit (AC3887)
Cat.#: ASET-2476
Specifications
Description Human Syndecan 4 ELISA Kit allows for the in vitro quantitative determination of human Syndecan 4 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.938 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.563-100 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1913 Rat Tau ELISA Kit (AC3324) Quantitative inquiry ASET-2046 Human Activin B ELISA Kit (AC3457) Quantitative inquiry ASET-1987 Mouse DCAMKL1 ELISA Kit (AC3398) Quantitative inquiry ASET-2505 Rat Luteinizing Hormone ELISA Kit (AC3916) Quantitative inquiry ASET-1009 Rat Apelin ELISA Kit (AC2420) Quantitative inquiry ASET-2030 Human p75 NGF Receptor ELISA Kit (AC3441) Quantitative inquiry ASET-2387 Human Dynamin 1 ELISA Kit (AC3798) Quantitative inquiry ASET-1857 Human DLL1 ELISA Kit (AC3268) Quantitative inquiry ASET-1551 Human alpha 2a Adrenergic Receptor ELISA Kit (AC2962) Quantitative inquiry ASET-2446 Human Tau ELISA Kit (AC3857) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket